PHILADELPHIA, Pennsylvania, JULY 29, 2007 (Zenit.org).- A prominent bioethicist says he hopes that the closure of ES Cell International, a leading embryonic stem cell research facility, is a sign of growing realism.
Father Tadeusz Pacholczyk commented on the closure of the biotechnology firm in Singapore, telling ZENIT, "We can only hope that a certain realism may finally be sinking in, as Wall Street types recognize that the timeline for clinical therapies is likely to be quite long."
The firm closed when investors concluded that "the likelihood of having products in the clinic in the short term was vanishingly small," Alan Colman, former chief executive of ES Cell International, told Science magazine…
| A.M.D.G. | ||||
As A.M.D.G. comments we hope this is a trend, but surely ESCR advocates will only put more pressure on state and federal governments here and the U.S. and governments throughout the world to fund this research. Too bad it was economics not ethics that lead to this. Unfortunately neither ethics or economics are deterrents to governments.
